Integrin‐Enriched Membrane Nanocarrier for the Specific Delivery of RGD‐modified Relaxin Analog to Inhibit Pancreatic Cancer Liver Metastasis through Reversing Hepatic Stellate Cell Activation-Reference-Cited by-同舟云学术

Integrin‐Enriched Membrane Nanocarrier for the Specific Delivery of RGD‐modified Relaxin Analog to Inhibit Pancreatic Cancer Liver Metastasis through Reversing Hepatic Stellate Cell Activation

Published:2022-09-16 Issue:47 Volume:32 Page:2208404
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv Funct Materials

Author:

Zhang Lijing¹,Li Zian¹²,Wang Fazhan¹,Chen Qiang¹,Zu Mali³⁴,Li Xingfan³⁴,Wan Jiajia¹,Yao Xiaohan¹,Lou Xiaohan¹,Shi Yupeng¹,Sheng Yuqiao¹,Wang Ming¹,Yang Jinjian¹,Wang Xinjun²,Qin Zhihai¹,Ji Tianjiao¹³⁴^ORCID

Affiliation:

1. Medical Research Center The First Affiliated Hospital of Zhengzhou University Zhengzhou University Zhengzhou 450052 P. R. China

2. Department of Neurosurgery the Fifth Affiliated Hospital of Zhengzhou University Zhengzhou University Zhengzhou 450052 P. R. China

3. CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety CAS Center for Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 P. R. China

4. Center of Materials Science and Optoelectronics Engineering University of Chinese Academy of Sciences Beijing 100049 P. R. China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adfm.202208404

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries